AMANTADINE FOR PREVENTION OF WEIGHT GAIN IN FIRST EPIDSODE ADULT PSYCHOTIC SUBJ

金刚烷胺用于预防成人精神病首发患者体重增加

• 批准号: 7377533
• 负责人: KAREN A GRAHAM
• 金额: $ 0.25万
• 依托单位: UNIV OF NORTH CAROLINA CHAPEL HILL
• 依托单位国家: 美国
• 财政年份: 2005
• 资助国家: 美国
• 起止时间: 2005-12-01 至 2006-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7377533
• 关键词: AMANTADINE; PREVENTION; WEIGHT; GAIN; FIRST

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this research is to determine if a medication called amantadine can prevent weight gain while taking olanzapine.

该子项目是利用NIH/NCRR资助的中心赠款提供的资源的许多研究子项目之一。子项目和研究者（PI）可能从另一个NIH来源获得主要资金，因此可以在其他CRISP条目中表示。所列机构为中心，不一定是研究者所在机构。这项研究的目的是确定一种名为金刚烷胺的药物是否可以防止服用奥氮平时体重增加。